Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Treating Climacteric Symptoms With a Complex Homeopathic Remedy

This study has been completed.
Wala GmbH
Information provided by:
Heidelberg University Identifier:
First received: September 8, 2005
Last updated: April 18, 2007
Last verified: April 2007
The purpose of this study is to determine whether ovaria comp. is effective in relieving climacteric symptoms.

Condition Intervention Phase
Anxiety Disorders
Drug: ovaria comp 10 globuli 3 times per day
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Treatment of Climacteric Symptoms With Ovaria Comp - A Prospective Randomized Placebo Controlled Doubleblind Study

Resource links provided by NLM:

Further study details as provided by Heidelberg University:

Primary Outcome Measures:
  • Climacteric symptoms measured as the difference of the sum score of the menopause rating scale before and after 12 weeks of treatment

Secondary Outcome Measures:
  • Climacteric symptoms measured as the difference of the subscales of the menopause rating scale before and after 12 weeks of treatment
  • Follow-up for another 12 weeks of treatment or after cross-over to the placebo group
  • Follow-up for cross-over to placebo after 24 weeks of treatment
  • Diurnal profile of cortisol level before and after treatment phases
  • Anxiety and depression measured by Hospital Anxiety and Depression Scale (HADS-D) before and after treatment period

Estimated Enrollment: 102
Study Start Date: February 2005
Study Completion Date: December 2006
Detailed Description:

Complementary treatments for climacteric symptoms are used by many women although their efficacy and safety is mostly unproven.

The use of the complex homeopathic remedy Ovaria comp. for the relief of climacteric symptoms will be examined in this three-armed intervention trial and measured with the menopause rating scale II before and after each study phase of 12 weeks. Participants will receive the verum during two treatment phases of 12 weeks and the placebo during one treatment phase of 12 weeks in different sequences and are stratified for post- and perimenopausal status.


Ages Eligible for Study:   45 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Climacteric symptoms>=3 Points in Menopause Rating Scale (MRS) II
  • Communication possible

Exclusion Criteria:

  • Hormone replacement therapy within 2 weeks prior to study inclusion
  • Other complementary treatments 7 days before and during the study
  • Climacteric symptoms caused by operation, chemotherapy or hormonal therapy of cancer
  • Allergy to components of the remedy, especially bee poison
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00152776

Department of Complementary and Integrative Medicine
Heidelberg, Baden-Württemberg, Germany, D-69115
Sponsors and Collaborators
Heidelberg University
Wala GmbH
Principal Investigator: Cornelia U von Hagens, MD Heidelberg University
  More Information Identifier: NCT00152776     History of Changes
Other Study ID Numbers: HD04
Study First Received: September 8, 2005
Last Updated: April 18, 2007

Keywords provided by Heidelberg University:
menopausal symptoms
complementary medicine

Additional relevant MeSH terms:
Anxiety Disorders
Mental Disorders processed this record on May 25, 2017